LAURA ROQUE: Open Payments
NPI 1720581887 · IJAMSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 27 payments from 11 companies in 2025. Trend: 2023 $737 · 2024 $661 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Lilly USA, LLC | 3 | $89 |
| Globus Medical, Inc. | 1 | $62 |
| ABBVIE INC. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $24 |
| Almatica Pharma LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: MOUNJARO, Ozempic, Wegovy, Senza, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, BREZTRI.
Industry payments across MD — which companies pay providers there.
